Literature DB >> 1537543

Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi.

R Cevenini1, V Sambri, F Massaria, M La Placa, E Brocchi, F De Simone.   

Abstract

Murine monoclonal antibodies (mAbs) were obtained against the outer-surface-protein OspA and OspB and against the 41-kDa flagellar antigen of Borrelia burgdorferi. The specificity of mAb was determined by the Western blotting technique and the surface association of the antigens was inferred by immunofluorescence of living bacteria. In an in vitro assay in the presence of complement, two mAbs reactive with the Ospa were able to kill borreliae, whereas several mAbs reactive with the OspA as well as with the 41-kDa flagellar protein were not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537543     DOI: 10.1016/0378-1097(92)90619-y

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Specific antibodies reactive with the 22-kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection.

Authors:  V Sambri; A Marangoni; A Olmo; E Storni; M Montagnani; M Fabbi; R Cevenini
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Surface immunofluorescence assay for diagnosis of Lyme disease.

Authors:  R Cevenini; V Sambri; F Massaria; R Franchini; A D'Antuono; G Borda; M Negosanti
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Development and optimization of OspC chimeritope vaccinogens for Lyme disease.

Authors:  Jerilyn R Izac; Nathaniel S O'Bier; Lee D Oliver; Andrew C Camire; Christopher G Earnhart; DeLacy V LeBlanc Rhodes; Brandon F Young; Stuart R Parnham; Christopher Davies; Richard T Marconi
Journal:  Vaccine       Date:  2020-01-17       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.